|Bid||5.47 x 1000|
|Ask||5.52 x 900|
|Day's Range||5.22 - 5.50|
|52 Week Range||1.22 - 12.49|
|Beta (5Y Monthly)||0.51|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jun 24, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||8.00|
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its fourth quarter fiscal year 2021, ended March 31, 2021, at 4:15 p.m. ET on Thursday, June 24, 2021.
In this article we will check out the progression of hedge fund sentiment towards Aethlon Medical, Inc. (NASDAQ:AEMD) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and […]
Heriot-Watt University in Edinburgh, student Thushira Kumarage joins Yahoo Finance's Myles Udland, Julie Hyman and Brian Sozzi to discuss retail trading and meme stocks.